Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2022 - IJCMAS--ICV 2022: 95.28 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020] For more details click here

Login as a Reviewer


See Guidelines to Authors
Current Issues
Download Publication Certificate

Original Research Articles                      Volume : 11, Issue:9, September, 2022

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com /
submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2022.11(9): 222-234
DOI: https://doi.org/10.20546/ijcmas.2022.1109.025


Evaluation of Ayurvedic Nanoparticle Drug Rasamanikya against ESBL Producing Gastrointestinal Gram-negative Bacteria Escherichia coli in Experimental Poultry
Bithika Halder1*, Samar Sarkar1, Samiran Bandapadhyay2, Prasanta Kumar Sarkar3,
Amit Raj Gupta1, Subhasish Batabyal4 and KoushikPal5
1Department of Veterinary Medicine, Ethics and Jurisprudence, W.B.U.A.F.S., Kolkata-37,
West Bengal, India
2Indian Veterinary Research Institute (IVRI), Kolkata-37, West Bengal, India
3Department of Rasashastra, J.B. Roy State Ayurvedic Medical College and Hospital,
Kolkata, 700004, West Bengal, India
4Department of Veterinary Biochemistry, W.B.U.A.F.S., Kolkata-37, West Bengal. India
5Department of Animal Science, KVK, Ashokenagar, North 24 Parganas, 743223, West Bengal, India
*Corresponding author
Abstract:

The present study investigate the effects of oral administration of ayurvedic nanoparticle drug Rasamanikya against ESBL producing gastrointestinal gram-negative bacteria Escherichia coli in experimental broiler chicken and haemato-biochemical, pathological alteration due to drug administration. At the age of 21 days, the birds were divided into three groups i.e. group-C served as control group, group-E treated with Enrofloxacin which act as standard control group and group-RM treated with test drug Rasamanikya, containing six birds in each group. On the day 22, the experiment (Drug trial) was started and continued for next 28 days. On the day 0, 7, 14, 21 and 28 of experiment fecal sample was collected by using fecal swab from each bird of three groups to examine the ESBL producing gastrointestinal gram-negative bacterial count. Blood sample also be collected on day 0, 7, 14 and 28 of experiment from wing vein with the help of tuberculin syringe in sterile vial under aseptic condition to evaluate the haemato-biochemical parameters i.e. Hb%, SGPT, SGOT, ALP, Urea and Creatinine. After 28 days of experiment, at the age of 50th day, the birds were slaughtered to collect tissue sample from heart, lung, liver and kidney. Illeo-caecal junction tissue was also collected to examine the illeo-caecal coliform count. Fecal coliform count decreased significantly in RM treated group in comparison to control group. There was no significant (P< 0.01) alteration in hemoglobin percentage, uric acid and creatinine level but serum SGPT, SGOT and ALP increased significantly in RM treated group. The illeo-caecal coliform count was decreased significantly in standard control and Rasa Manikya treated groups in both dilutions 1:50 and 1:100 in comparison to normal control group. The result indicate that the test drug Rasamanikya able to decrease the fecal and illeo-caecal coliform count but histopathological findings clearly showed the drug causes chronic toxicity in birds of RM treated group.


Keywords: ESBL, Escherichia coli, broiler, Ayurvedic nanoparticle drug, rasamanikya, toxicity

Download this article as Download

How to cite this article:

Bithika Halder, Samar Sarkar, Samiran Bandapadhyay, Prasanta Kumar Sarkar, Amit Raj Gupta, Subhasish Batabyal and Koushik Pal. 2022. Evaluation of Ayurvedic Nanoparticle Drug Rasamanikya against ESBL Producing Gastrointestinal Gram-negative Bacteria Escherichia coli in Experimental Poultry.Int.J.Curr.Microbiol.App.Sci. 11(9): 222-234. doi: https://doi.org/10.20546/ijcmas.2022.1109.025
Copyright: This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike license.

Citations